These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 15227627)

  • 1. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
    Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella seroprevalence among women aged 15-39 years in Morocco.
    Caidi H; Bloom S; Azilmaat M; Benjouad A; Reef S; El Aouad R
    East Mediterr Health J; 2009; 15(3):526-31. PubMed ID: 19731768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiologic situation of rubella in Italy 20 years after the introduction of the vaccine].
    Galli MG
    Ann Ig; 1989; 1(1-2):247-54. PubMed ID: 2483071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey?
    Aksakal FN; Maral I; Cirak MY; Aygun R
    Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
    Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India.
    Vijayalakshmi P; Anuradha R; Prakash K; Narendran K; Ravindran M; Prajna L; Brown D; Robertson SE
    Bull World Health Organ; 2004 Apr; 82(4):259-64. PubMed ID: 15259254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella susceptibility in young adults.
    Allen S; Mason C; Holloway RL
    J Fam Pract; 1985 Oct; 21(4):271-5. PubMed ID: 4045394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
    Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria.
    Bukbuk DN; el Nafaty AU; Obed JY
    Cent Eur J Public Health; 2002 Jun; 10(1-2):21-3. PubMed ID: 12096678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
    Doerr HW; Geisen HP; Kapp M; Schmidt W
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1316-20. PubMed ID: 6257468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of rubella prevention in Austria (1988 status)].
    Hofmann H; Kunz C
    Wien Med Wochenschr; 1989 Jul; 139(14):330-3. PubMed ID: 2773490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey.
    Seker S; Abasiyanik MF; Salih BA
    Saudi Med J; 2004 May; 25(5):575-9. PubMed ID: 15138523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to rubella virus among Sri Lankan women.
    Mendis L
    Ceylon Med J; 1989 Jun; 34(2):73-5. PubMed ID: 2620371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.